Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer—Letter

Moroz and colleagues showed the antitumor activity of radiolabeled antibodies directed against CDCP1 in preclinical models of pancreatic carcinoma ([1][1]). Pancreatic carcinoma is one of the most aggressive human cancers. Complete surgical resection followed by chemotherapy is the only available